MedTrace Logo

Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus

NCT06152796 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2023-12-01

No results posted yet for this study

Summary

To compare efficacy and safety of paracetamol and ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in preterm infants.

Conditions

  • Patent Ductus Arteriosus

Interventions

DRUG

Paracetamol

Anti\_inflammatory drug

DRUG

Ibuprofen

Non steroidal anti\_inflammatory drug

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
28 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-09-01
Completion
2026-01-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06152796 on ClinicalTrials.gov